Spectrum Therapeutics, the medical division of Canopy Growth (NYSE:CGC,TSX:WEED), announced a five year service agreement with Medical Pharmacies Group.
As quoted in the press release:
Under the agreement, Spectrum Therapeutics will be the preferred medical cannabis education partner to Medical Pharmacies and the seniors it serves in over 500 residences and care facilities.
“Many seniors still face significant barriers when it comes to access and knowledge around the therapeutic value of medical cannabis,” said Dr. Mark Ware, Chief Medical Officer, Canopy Growth. “However with the knowledge and support of trained pharmacists along with Apollo Cannabis Clinics and our full-spectrum range of medical cannabis which includes Softgels, a consistent dosing format of ingestible medical cannabis, we’re ensuring the highest degree of safety and efficacy of medical cannabis is available to this patient population.”
Click here to read the full press release.
The post Spectrum Therapeutics Announces Partnership with Medical Pharmacies appeared first on Investing News Network.